Does SITAGLIPTIN Cause Lung neoplasm malignant? 28 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Lung neoplasm malignant have been filed in association with SITAGLIPTIN (JANUVIA). This represents 0.1% of all adverse event reports for SITAGLIPTIN.
28
Reports of Lung neoplasm malignant with SITAGLIPTIN
0.1%
of all SITAGLIPTIN reports
13
Deaths
14
Hospitalizations
How Dangerous Is Lung neoplasm malignant From SITAGLIPTIN?
Of the 28 reports, 13 (46.4%) resulted in death, 14 (50.0%) required hospitalization, and 3 (10.7%) were considered life-threatening.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SITAGLIPTIN. However, 28 reports have been filed with the FAERS database.
What Other Side Effects Does SITAGLIPTIN Cause?
Blood glucose increased (1,427)
Pancreatic carcinoma (1,142)
Product dose omission issue (1,125)
Drug ineffective (1,057)
No adverse event (994)
Nausea (936)
Pancreatitis (922)
Diabetes mellitus inadequate control (744)
Diarrhoea (712)
Hypoglycaemia (674)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which SITAGLIPTIN Alternatives Have Lower Lung neoplasm malignant Risk?
SITAGLIPTIN vs SOAP
SITAGLIPTIN vs SODIUM
SITAGLIPTIN vs SODIUM BICARBONATE
SITAGLIPTIN vs SODIUM BICARBONATE\SODIUM
SITAGLIPTIN vs SODIUM BORATE